Literature DB >> 6372928

The LD50 for uniform low LET irradiation of man.

R H Mole.   

Abstract

Previously published estimates of the whole-body radiation dose expected to kill 50% of a normal human population, the LD50, have rarely been based explicitly on evidence. The difference which might result from medical treatment seems to have been markedly over-valued. The available and relevant evidence about severe haematopoietic damage in man uncomplicated by tissue necrosis is indeed very scanty. It comes from 20 cases of therapeutic whole-body exposure to gamma rays and from two criticality accidents involving nine subjects, one of whom died, and when exposure was to neutrons as well as gamma rays. The observations suggest a judgment that 4.5 Gy (450 rad) absorbed dose in the bone marrow for energetic and therefore penetrating gamma rays giving reasonably uniform irradiation of the marrow could be regarded as the LD50 in circumstances where those irradiated were protected from thermal radiation and blast damage and from neutrons and beta rays. Examination of all the available experimental data on acute lethality following whole-body exposure to low LET radiation shows a remarkably similar co-efficient of variation of the LD50 in five species of large animal. If the same value is adopted for the human species, a quantitative estimate of the human LD50 can be inferred from the human evidence discussed. This reinforces the judgement that it is about 4.5 Gy. The use of observations after criticality accidents is examined in detail in an Appendix. The Vinca accident does not clearly meet the criteria for relevancy but there is no other instance of death in man from an uncomplicated brief whole-body exposure to ionising radiation where the bone-marrow dose can be estimated, and a possible judgment made of the value for the LD50.

Entities:  

Mesh:

Year:  1984        PMID: 6372928     DOI: 10.1259/0007-1285-57-677-355

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  21 in total

1.  Point/counterpoint. Radiotherapy is an appropriate treatment to consider for patients infected with the Ebola virus.

Authors:  Wilfred F Ngwa; Roland Teboh; Colin G Orton
Journal:  Med Phys       Date:  2015-03       Impact factor: 4.071

2.  Lifetime Mortality Risk from Cancer and Circulatory Disease Predicted from the Japanese Atomic Bomb Survivor Life Span Study Data Taking Account of Dose Measurement Error.

Authors:  Mark P Little; David Pawel; Munechika Misumi; Nobuyuki Hamada; Harry M Cullings; Richard Wakeford; Kotaro Ozasa
Journal:  Radiat Res       Date:  2020-09-16       Impact factor: 2.841

3.  Late Effects of Radiation Prime the Brain Microenvironment for Accelerated Tumor Growth.

Authors:  Chong Duan; Ruimeng Yang; Liya Yuan; John A Engelbach; Christina I Tsien; Keith M Rich; Sonika M Dahiya; Tanner M Johanns; Joseph J H Ackerman; Joel R Garbow
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-08-30       Impact factor: 7.038

4.  Low-dose radiation exposure induces a HIF-1-mediated adaptive and protective metabolic response.

Authors:  R Lall; S Ganapathy; M Yang; S Xiao; T Xu; H Su; M Shadfan; J M Asara; C S Ha; I Ben-Sahra; B D Manning; J B Little; Z-M Yuan
Journal:  Cell Death Differ       Date:  2014-02-28       Impact factor: 15.828

Review 5.  DNA damage and tissue repair: What we can learn from planaria.

Authors:  Paul G Barghouth; Manish Thiruvalluvan; Melanie LeGro; Néstor J Oviedo
Journal:  Semin Cell Dev Biol       Date:  2018-05-03       Impact factor: 7.727

6.  Inhibitors of HIF-1α and CXCR4 Mitigate the Development of Radiation Necrosis in Mouse Brain.

Authors:  Ruimeng Yang; Chong Duan; Liya Yuan; John A Engelbach; Christina I Tsien; Scott C Beeman; Carlos J Perez-Torres; Xia Ge; Keith M Rich; Joseph J H Ackerman; Joel R Garbow
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-12-21       Impact factor: 7.038

7.  Relative merits and limiting factors for x-ray and electron microscopy of thick, hydrated organic materials.

Authors:  Ming Du; Chris Jacobsen
Journal:  Ultramicroscopy       Date:  2017-10-07       Impact factor: 2.689

8.  Radiation-induced biomarkers for the detection and assessment of absorbed radiation doses.

Authors:  Sudha Rana; Raj Kumar; Sarwat Sultana; Rakesh Kumar Sharma
Journal:  J Pharm Bioallied Sci       Date:  2010-07

Review 9.  Experimental evolution of extremophile resistance to ionizing radiation.

Authors:  Steven T Bruckbauer; Michael M Cox
Journal:  Trends Genet       Date:  2021-06-01       Impact factor: 11.821

10.  Can Polymetastatic Disease Be ARRESTed Using SABR? A Dosimetric Feasibility Study to Inform Development of a Phase 1 Trial.

Authors:  Mark T Corkum; Hatim Fakir; David A Palma; Timothy Nguyen; Glenn S Bauman
Journal:  Adv Radiat Oncol       Date:  2021-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.